Treatment Persistence for Infliximab Versus Adalimumab in Crohn's Disease: A 14-Year Single-Center Experience.

about

Treatment Persistence for Infliximab Versus Adalimumab in Crohn's Disease: A 14-Year Single-Center Experience.

Item

http://www.wikidata.org/entity/Q38883385

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Treatment Persistence for Infl ...... Year Single-Center Experience.

@en

type

Item

label

Treatment Persistence for Infl ...... Year Single-Center Experience.

@en

prefLabel

Treatment Persistence for Infl ...... Year Single-Center Experience.

@en

P1476

Treatment Persistence for Infl ...... Year Single-Center Experience.

@en

P2093

Amandine Luc

http://www.w3.org/2001/XMLSchema#string

Cedric Baumann

http://www.w3.org/2001/XMLSchema#string

Linda Thiriet

http://www.w3.org/2001/XMLSchema#string

Pablo Olivera

http://www.w3.org/2001/XMLSchema#string

Silvio Danese

http://www.w3.org/2001/XMLSchema#string

P2860

Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial

Certolizumab pegol for the treatment of Crohn's disease

Human anti-tumor necrosis factor monoclonal antibody (adalimumab) in Crohn's disease: the CLASSIC-I trial

Drug retention rates and treatment discontinuation among anti-TNF-α agents in psoriatic arthritis and ankylosing spondylitis in clinical practice.

Changes in disease characteristics and response rates among patients in the United Kingdom starting anti-tumour necrosis factor therapy for rheumatoid arthritis between 2001 and 2008.

Impact of concomitant use of DMARDs on the persistence with anti-TNF therapies in patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register

The efficacy of anti-TNF in rheumatoid arthritis, a comparison between randomised controlled trials and clinical practice.

The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications.

Medication compliance and persistence: terminology and definitions.

Persistence with anti-tumour necrosis factor therapies in patients with psoriatic arthritis: observational study from the British Society of Rheumatology Biologics Register

P304

976-985

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/MIB.0000000000001072

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Laurent Peyrin-Biroulet

P577

2017-03-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28333755

http://www.w3.org/2001/XMLSchema#string

P921

adalimumab